dexmedetomidine has been researched along with amifostine anhydrous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Birinci, M; Celebi Erdivanlı, O; Celiker, M; Cinar, S; Demir, E; Dursun, E; Karakaş, S; Mercantepe, T; Ozergin Coşkun, Z; Rakici, S; Safak, G; Terzi, S; Tümkaya, L; Yilmaz, A | 1 |
1 review(s) available for dexmedetomidine and amifostine anhydrous
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for dexmedetomidine and amifostine anhydrous
| Article | Year |
|---|---|
Comparison of effects of dexmedetomidine and amifostine against X-ray radiation-induced parotid damage.
Topics: Amifostine; Animals; Dexmedetomidine; Fibrosis; Glutathione; Oxidative Stress; Parotid Gland; Rats; Rats, Sprague-Dawley; X-Rays | 2022 |